Drug Profile
Research programme: angiogenesis inhibitors - ATON
Alternative Names: Angiogenesis inhibitor research programme - ATONLatest Information Update: 28 Sep 2023
Price :
$50
*
At a glance
- Originator Hybrigenics
- Class
- Mechanism of Action Angiogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer